12-Month Evaluation of Dexamethasone Intravitreal Implant in Patients With Macular Edema Due to Central Retinal Vein Occlusion

被引：0
|
作者：
Bandello, F. [1 ]
Blumenkranz, M. S. [2 ]
Jiao, J. [3 ]
Li, X. -Y. [4 ]
Whitcup, S. M. [5 ]
机构：
[1] Univ Vita Salute, Ophthalmol, Milan, Italy
[2] Stanford Univ, Sch Med, Ophthalmol, Stanford, CA 94305 USA
[3] Allergan Pharmaceut Inc, Irvine, CA USA
[4] Allergan Pharmaceut Inc, Clin Ophthalmol, Irvine, CA USA
[5] Allergan Pharmaceut Inc, R&D, Irvine, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
macula/fovea; corticosteroids;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6397
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of Dexamethasone Intravitreal Implant Compared with Intravitreal Ranibizumab in Patients with Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion
    Aydin, Erdinc
    Gurakar, Seda
    Egrilmez, Emine Deniz
    OPHTHALMOLOGICA, 2014, 232 : 87 - 87
  • [42] Evaluation of Intravitreal Dexamethasone Implant (OzurdexTM) in the Treatment of Refractory Macular Edema in Patients With Retinal Vein Occlusions
    Mojica, G. J.
    Fernandes, J. K.
    Hariprasad, S. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [43] Outcome After ≥6 Intravitreal Dexamethasone Implants For Macular Edema Due To Retinal Vein Occlusion
    Bhende, Muna
    Jain, Smriti
    Attiku, Yamini
    Raman, Rajiv
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [44] A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
    Callanan, David G.
    Loewenstein, Anat
    Patel, Sunil S.
    Massin, Pascale
    Corcostegui, Borja
    Li, Xiao-Yan
    Jiao, Jenny
    Hashad, Yehia
    Whitcup, Scott M.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 463 - 473
  • [45] A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
    David G. Callanan
    Anat Loewenstein
    Sunil S. Patel
    Pascale Massin
    Borja Corcóstegui
    Xiao-Yan Li
    Jenny Jiao
    Yehia Hashad
    Scott M. Whitcup
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 463 - 473
  • [46] Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion
    Bashshur, ZF
    Ma'luf, RN
    Allam, S
    Jurdi, FA
    Haddad, RS
    Noureddin, BN
    ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (08) : 1137 - 1140
  • [47] Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study
    C. Chiquet
    C. Dupuy
    A. M. Bron
    F. Aptel
    M. Straub
    R. Isaico
    J. P. Romanet
    C. Creuzot-Garcher
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 2095 - 2102
  • [48] Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-na⟨ve patients with retinal vein occlusion and macular edema: a 12-month follow-up study
    Chiquet, C.
    Dupuy, C.
    Bron, A. M.
    Aptel, F.
    Straub, M.
    Isaico, R.
    Romanet, J. P.
    Creuzot-Garcher, C.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (12) : 2095 - 2102
  • [49] A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion
    Bandello, Francesco
    Augustin, Albert
    Tufail, Adnan
    Leaback, Richard
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 (06) : 697 - 705
  • [50] Intravitreal Injection of Conbercept Combined with Dexamethasone for Macular Edema Following Central Retinal Vein Occlusion
    Wu, Peipei
    Zhang, Panpan
    Xu, Jing
    Ma, Wenhui
    Li, Longfei
    Xu, Haifeng
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1851 - 1860
12345